Literature DB >> 16455387

Serum leptin levels in patients with allergic rhinitis.

Murat Unal1, Gülçin Eskandari, Necati Muşlu, Yavuz Selim Pata, Yücel Akbaş.   

Abstract

OBJECTIVE: To investigate the serum leptin levels in patients with allergic rhinitis during the symptomatic period. STUDY DESIGN AND
SETTING: A randomized, prospective study was performed on 26 adult patients with allergic rhinitis and 20 control subjects with similar age, sex and body mass index in a tertiary otolaryngology center.
RESULTS: Leptin levels were 28.8 +/- 14.1 ng/mL in the patients with allergic rhinitis, and 20.8 +/- 13.5 ng/mL in the control group respectively. The difference between the groups was statistically significant (p = 0.04).
CONCLUSION: Serum leptin levels were found to be significantly higher in patients with allergic rhinitis in symptomatic period. SIGNIFICANCE: Apart from its primary role in the regulation of body weight and energy expenditure, leptin may have a role in the inflammatory process of the allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455387     DOI: 10.1016/j.otohns.2005.11.021

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

1.  The effects of allergic rhinitis on growth, development and body mass indexes in school children.

Authors:  Mustafa Paksoy; Mehmet Eken; Sedat Aydın; Z Alev Oktay; Umit Hardal; Arif Sanlı; Neslihan Y Zeren
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-06-04

Review 2.  Leptin in the Respiratory Tract: Is There a Role in SARS-CoV-2 Infection?

Authors:  Andreina Bruno; Giuliana Ferrante; Serena Di Vincenzo; Elisabetta Pace; Stefania La Grutta
Journal:  Front Physiol       Date:  2021-12-22       Impact factor: 4.566

3.  Leptin gene polymorphism affects leptin level in childhood asthma.

Authors:  Dawid Szczepankiewicz; Paulina Sobkowiak; Beata Narożna; Irena Wojsyk-Banaszak; Anna Bręborowicz; Aleksandra Szczepankiewicz
Journal:  World J Pediatr       Date:  2018-09-10       Impact factor: 2.764

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.